University of Alabama
Researchers' findings from the United States and Japan advance diabetes research
Published in Law and Health Weekly, August 12th, 2006
Study 1: Ramipril treatment was linked to a lower risk of diabetes mellitus in African Americans with hypertensive kidney disease.
"The African American Study of Kidney Disease and Hypertension was a multicenter trial of African Americans with hypertensive kidney disease randomized to an angiotensin-converting enzyme inhibitor (ramipril), a beta-blocker (metoprolol succinate), or a calcium channel blocker (amlodipine besylate). We compared the incidence of type 2 diabetes mellitus (DM) and the composite outcome of impaired fasting glucose or DM (IFG/DM) for the African...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- American Medical Association
Anti-retroviral therapies associated with reduced infections in HIV-infected children - Aradigm
Aradigm and Novo Nordisk execute further restructuring of partnership - Columbia University, U.S.
Researchers discover a protein in nerve cells that acts as a switch for chronic pain - Cozart
Cozart secures U.S. patent for lead products RapiScan and DDS - Harvard University
Recent findings from the United States illuminate research in vectors - Market Analysis
Medicare plans average 88 drugs in formularies while private plans have 15 to 20, report says - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
